Encompass Health Corporation $EHC Shares Sold by Segall Bryant & Hamill LLC

Segall Bryant & Hamill LLC cut its position in Encompass Health Corporation (NYSE:EHC) by 28.2% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 127,903 shares of the company’s stock after selling 50,200 shares during the quarter. Segall Bryant & Hamill LLC’s holdings in Encompass Health were worth $16,246,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Tectonic Advisors LLC boosted its position in Encompass Health by 1.6% in the 3rd quarter. Tectonic Advisors LLC now owns 5,337 shares of the company’s stock valued at $678,000 after buying an additional 82 shares during the last quarter. Global Retirement Partners LLC boosted its holdings in Encompass Health by 23.0% in the third quarter. Global Retirement Partners LLC now owns 449 shares of the company’s stock valued at $57,000 after purchasing an additional 84 shares during the last quarter. EP Wealth Advisors LLC boosted its holdings in Encompass Health by 2.4% in the second quarter. EP Wealth Advisors LLC now owns 3,694 shares of the company’s stock valued at $453,000 after purchasing an additional 88 shares during the last quarter. Natural Investments LLC grew its stake in Encompass Health by 1.2% during the 3rd quarter. Natural Investments LLC now owns 7,808 shares of the company’s stock valued at $991,000 after purchasing an additional 89 shares in the last quarter. Finally, TD Private Client Wealth LLC raised its position in shares of Encompass Health by 1.1% in the 3rd quarter. TD Private Client Wealth LLC now owns 8,216 shares of the company’s stock valued at $1,044,000 after purchasing an additional 91 shares in the last quarter. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Insider Transactions at Encompass Health

In other news, CEO Mark J. Tarr sold 150,000 shares of the business’s stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $111.64, for a total transaction of $16,746,000.00. Following the completion of the transaction, the chief executive officer owned 377,070 shares of the company’s stock, valued at approximately $42,096,094.80. The trade was a 28.46% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Insiders own 2.10% of the company’s stock.

Encompass Health Trading Down 0.1%

NYSE EHC opened at $107.94 on Wednesday. The firm has a market capitalization of $10.73 billion, a PE ratio of 19.48, a price-to-earnings-growth ratio of 2.07 and a beta of 0.71. Encompass Health Corporation has a one year low of $92.53 and a one year high of $127.99. The company has a 50-day simple moving average of $103.89 and a 200-day simple moving average of $113.88. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.08 and a current ratio of 1.08.

Encompass Health (NYSE:EHC) last issued its earnings results on Thursday, February 5th. The company reported $1.46 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.29 by $0.17. The firm had revenue of $3.09 billion for the quarter, compared to analysts’ expectations of $1.54 billion. Encompass Health had a net margin of 9.54% and a return on equity of 18.20%. Encompass Health’s revenue was up 9.9% on a year-over-year basis. During the same quarter last year, the company posted $1.17 earnings per share. Encompass Health has set its FY 2026 guidance at 5.810-6.100 EPS. On average, equities analysts forecast that Encompass Health Corporation will post 4.8 earnings per share for the current year.

Encompass Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 15th. Investors of record on Wednesday, April 1st will be paid a dividend of $0.19 per share. This represents a $0.76 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date is Wednesday, April 1st. Encompass Health’s dividend payout ratio is presently 13.72%.

Analyst Upgrades and Downgrades

EHC has been the subject of a number of research analyst reports. Barclays lifted their price target on shares of Encompass Health from $150.00 to $153.00 and gave the stock an “overweight” rating in a research note on Friday, February 6th. Wall Street Zen upgraded Encompass Health from a “hold” rating to a “buy” rating in a research note on Sunday, January 18th. Finally, Zacks Research cut Encompass Health from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, November 19th. Two investment analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Buy” and an average price target of $143.29.

Encompass Health Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.